Search Results

There are 36992 results for: content related to: Warfarin treatment of chronic idiopathic urticaria and angio-oedema

  1. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  2. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  3. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  4. You have full text access to this OnlineOpen article
    Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 353–363, Dagmar Kubitza, Michael Becka, Wolfgang Mück and Jöern Krätzschmar

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12349

  5. The Effect of Etoricoxib on the Pharmacodynamics and Pharmacokinetics of Warfarin

    The Journal of Clinical Pharmacology

    Volume 47, Issue 5, May 2007, Pages: 620–627, Dr Jules I. Schwartz, Dr Nancy G. B. Agrawal, Dr Alan H. Hartford, Mr Josee Cote, Dr Thomas L. Hunt, Dr Rene Verbesselt, Mr Dane R. Eckols and Dr Keith M. Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007299758

  6. Effect of Casopitant, a Novel NK-1 Receptor Antagonist, on the Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin

    The Journal of Clinical Pharmacology

    Volume 50, Issue 5, May 2010, Pages: 566–575, Dr Lyndon C. Kirby, Dr Brendan M. Johnson, Dr Laurel M. Adams, Dr Derek J. Eberwein, Dr Ke Zhang, Dr Sharon C. Murray, Dr Christian D. Lates, Dr Robert A. Blum and Dr Shannon R. Morris

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009346965

  7. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 6, December 1999, Pages: 569–581, Harumi Takahashi, Teruki Sato, Yoshiaki Shimoyama, Noriko Shioda, Teppei Shimizu, Suzuko Kubo, Noboru Tamura, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen

    Version of Record online : 19 DEC 1999, DOI: 10.1053/cp.1999.v66.103378001

  8. Major bleeding risk associated with warfarin and co-medications in the elderly population

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1057–1063, Agnes I. Vitry, Elizabeth E. Roughead, Emmae N. Ramsay, Adrian K. Preiss, Philip Ryan, Andrew L. Gilbert, Gillian E. Caughey, Sepehr Shakib, Adrian Esterman, Ying Zhang and Robyn A McDermott

    Version of Record online : 17 AUG 2011, DOI: 10.1002/pds.2219

  9. You have free access to this content
    Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy – A Population-Based Register Study

    Basic & Clinical Pharmacology & Toxicology

    Volume 117, Issue 2, August 2015, Pages: 126–132, Maria Rikala, Milka Hauta-Aho, Arja Helin-Salmivaara, Riitta Lassila, Maarit Jaana Korhonen and Risto Huupponen

    Version of Record online : 19 JAN 2015, DOI: 10.1111/bcpt.12373

  10. You have free access to this content
    Association of Warfarin Use With Valvular and Vascular Calcification: A Review

    Clinical Cardiology

    Volume 34, Issue 2, February 2011, Pages: 74–81, Chandrasekar Palaniswamy, Arunabh Sekhri, Wilbert S. Aronow, Ankur Kalra and Stephen J. Peterson

    Version of Record online : 6 FEB 2011, DOI: 10.1002/clc.20865

  11. Investigation of the Effects of Herbal Medicines on Warfarin Response in Healthy Subjects: A Population Pharmacokinetic-Pharmacodynamic Modeling Approach

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1370–1378, Dr Xuemin Jiang, Dr Elaine Y. L. Blair and Dr Andrew J. McLachlan

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006292124

  12. Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 561–574, Dr Linda M. Bavisotto, Dr David J. Ellis, Dr Peter G. Milner, Mr Daniel L. Combs, Mr Ian Irwin and Dr Daniel M. Canafax

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010370588

  13. You have free access to this content
    Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients

    British Journal of Clinical Pharmacology

    Volume 70, Issue 6, December 2010, Pages: 834–843, Brian E. Davies, Pau Aceves Baldó, Sian Lennon-Chrimes and Mike Brewster

    Version of Record online : 11 NOV 2010, DOI: 10.1111/j.1365-2125.2010.03780.x

  14. You have full text access to this OnlineOpen article
    Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 79, Issue 6, June 2015, Pages: 907–917, Kenneth Todd Moore, William Byra, Seema Vaidyanathan, Jaya Natarajan, Jay Ariyawansa, Hiba Salih and Kenneth C. Turner

    Version of Record online : 22 MAY 2015, DOI: 10.1111/bcp.12559

  15. A Regulatory Science Perspective on Warfarin Therapy: A Pharmacogenetic Opportunity

    The Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2009, Pages: 138–146, Myong-Jin Kim, Shiew-Mei Huang, Urs A. Meyer, Atiqur Rahman and Lawrence J. Lesko

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008328098

  16. Pharmacokinetics and Pharmacodynamics of Warfarin When Coadministered With Pentosan Polysulfate Sodium

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 919–926, Dr Nishit B. Modi, Dr Sherron Kell, Ms Mary Simon and Dr Ramon Vargas

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005278600

  17. You have full text access to this OnlineOpen article
    Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin

    The Journal of Clinical Pharmacology

    Volume 55, Issue 6, June 2015, Pages: 671–679, Grace Chen, Wencan Zhang and Michael Serenko

    Version of Record online : 4 FEB 2015, DOI: 10.1002/jcph.456

  18. Absence of a Pharmacokinetic Interaction between Etanercept and Warfarin

    The Journal of Clinical Pharmacology

    Volume 44, Issue 5, May 2004, Pages: 543–550, Dr Honghui Zhou, Dr Alain Patat, Ms Virginia Parks, Ms Mary Buckwalter, Dr Deborah Metzger and Dr Joan Korth-Bradley

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004264164

  19. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  20. Prospective Study of Warfarin Dosage Requirements Based on CYP2C9 and VKORC1 Genotypes

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 1, July 2008, Pages: 83–89, M-S Wen, MTM Lee, J-J Chen, H-P Chuang, L-S Lu, C-H Chen, T-H Lee, C-T Kuo, F-M Sun, Y-J Chang, P-L Kuan, Y-F Chen, M-J Charng, C-Y Ray, J-Y Wu and Y-T Chen

    Version of Record online : 9 JAN 2008, DOI: 10.1038/sj.clpt.6100453